English

Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio

On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on Eribulin Mesylate Injection, securing exclusive commercialization licensing and supply of the product from Xiling Lab Co., Ltd. in 36 countries. This is the fifth major breast cancer medication introduced by Kexing Biopharm, which further enriches its product portfolio for breast cancer treatment. […]

thaipr.net

8 ม.ค. 67

Kohler Brings Design Leadership and Smart Home Wellness Experiences to CES 2024

Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024. Kohler’s lineup marks a continued commitment to transforming homes into personal sanctuaries for comfort, self-care, and renewal.  Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9235552-kohler-leading-edge-design-innovation-smart-home-wellness-at-ces-2024/  …

thaipr.net

8 ม.ค. 67

Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications

The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients, along with clinical stage generative artificial intelligence (AI)-driven biotechnology company Insilico Medicine (“Insilico”), today announced…

thaipr.net

5 ม.ค. 67
1 … 823 824 825 826 827 … 3,167

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.